소아에서 마이코플라스마 폐렴과 바이러스 폐렴의 임상적 특징 비교: 다기관 단면연구
Clinical features of Mycoplasma pneumonia in comparison with viral pneumoina in children: A multicenter, cross-sectional study
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose: This study was conducted to compare clinical features between Mycoplasma pneumonia and viral pneumonia. Methods: We retrospectively analyzed the medical records of 428 patients requiring hospitalization among children younger than 18 years of age in 5 hospitals in Seoul and Gyeonggi-do. There were 131 patients with M. pneumonia and virus coinfection, 167 patients with M. pneumonia without virus coinfection, and 130 patients with viral pneumonia. All subjects had radiographic evidence of pneumonia with specimens available for both M. pneumonia and viral testing. Virus was identified using the polymerase chain reaction assay in a nasopharyngeal or oropharyngeal swab. M. pneumoniae pneumonia was diagnosed serologically. Results: Human rhinovirus was detected in 60.3% (79 of 131) of children with M. pneumonia accompanied by virus coinfection. Respiratory syncytial virus (RSV) was detected in 38.2% (50 of 130) of children with viral pneumonia. The mean age was significantly lower in the viral pneumonia group than in the M. pneumonia group with and without virus coinfection. The sex distribution did not differ significantly among the 3 study groups. The procalcitonin level was higher in viral pneumonia and erythrocyte sedimentation rate level was higher in the M. pneumonia group although no significant difference was found in C-reactive protein level between the M. pneumonia and viral pneumonia groups. Conclusion: Clinical features and inflammatory markers between M. pneumonia and viral pneumonia may be useful for the treatment of community-acquired pneumonia.
Abstract
Purpose: This study was conducted to compare clinical features between Mycoplasma pneumonia and viral pneumonia. Methods: We retrospectively analyzed the medical records of 428 patients requiring hospitalization among children younger than 18 years of age in 5 hospitals in Seoul and Gyeonggi-do. There were 131 patients with M. pneumonia and virus coinfection, 167 patients with M. pneumonia without virus coinfection, and 130 patients with viral pneumonia. All subjects had radiographic evidence of pneumonia with specimens available for both M. pneumonia and viral testing. Virus was identified using the polymerase chain reaction assay in a nasopharyngeal or oropharyngeal swab. M. pneumoniae pneumonia was diagnosed serologically. Results: Human rhinovirus was detected in 60.3% (79 of 131) of children with M. pneumonia accompanied by virus coinfection. Respiratory syncytial virus (RSV) was detected in 38.2% (50 of 130) of children with viral pneumonia. The mean age was significantly lower in the viral pneumonia group than in the M. pneumonia group with and without virus coinfection. The sex distribution did not differ significantly among the 3 study groups. The procalcitonin level was higher in viral pneumonia and erythrocyte sedimentation rate level was higher in the M. pneumonia group although no significant difference was found in C-reactive protein level between the M. pneumonia and viral pneumonia groups. Conclusion: Clinical features and inflammatory markers between M. pneumonia and viral pneumonia may be useful for the treatment of community-acquired pneumonia.
참고문헌 (30)
- Pfuntner A, "Healthcare Cost and Utilization Project (HCUP) Statistical Briefs" (2006), Agency for Healthcare Research and Quality (US)
- Lee GE, "National hospitalization trends for pediatric pneumonia and associated complications", Pediatrics, 126, pp.204~213 (2010)[DOI]
- Eun BW, "Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period", J Infect, 56, pp.326~331 (2008)[DOI]
- Niitu Y, "Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics", J Pediatr, 76, pp.438~443 (1970)[DOI]
- Dumke R, "Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany", Clin Microbiol Infect, 16, pp.613~616 (2010)[DOI]
- Peuchant O, "Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis", J Antimicrob Chemother, 64, pp.52~58 (2009)[DOI]
- Okada T, "Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children", Clin Infect Dis, 55, pp.1642~1649 (2012)[DOI]
- 장명웅, "Mycoplasma pneumoniae의 분리 및 항생제 감수성 검사(III)", 생명과학회지, 15(3), pp.479~485 (2005), 한국생명과학회
- Hong KB, "Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011", Emerg Infect Dis, 19, pp.1281~1284 (2013)[DOI]
- 이은, "Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children", Clinical and Experimental Pediatrics, 60(5), pp.151~157 (2017), 대한소아청소년과학회
- Ahn HS, "Hong Chang Eui pediatrics", pp.697~ (2016), Mirae N
- Sensini A, "Serological diagnosis of Mycoplasma pneumoniae infection: a complicated puzzle", Microbiol Med, 27, pp.171~176 (2012)
- Iwane MK, "Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children", J Infect Dis, 204, pp.1702~1710 (2011)[DOI]
- Hayden FG, "Rhinovirus and the lower respiratory tract", Rev Med Virol, 14, pp.17~31 (2004)[DOI]
- Jartti T, "Serial viral infections in infants with recurrent respiratory illnesses", Eur Respir J, 32, pp.314~320 (2008)[DOI]
- Garcia-Garcia ML, "Spectrum of respiratory viruses in children with community-acquired pneumonia", Pediatr Infect Dis J, 31, pp.808~813 (2012)[DOI]
- Jain S, "Community-acquired pneumonia requiring hospitalization among U.S. children", N Engl J Med, 372, pp.835~845 (2015)[DOI]
- Pavia AT, "Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis", Clin Infect Dis, 52(Suppl 4), pp.S284~S289 (2011)[DOI]
- Bradley JS, "The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America", Clin Infect Dis, 53, pp.e25~e76 (2011)[DOI]
- Jacobs JW, "Procalcitonin is a glycoprotein", J Biol Chem, 256, pp.2803~2807 (1981)
- Reinhart K, "Procalcitonin as a marker of the systemic inflammatory response to infection", Intensive Care Med, 26, pp.1193~1200 (2000)[DOI]
- Becker KL, "Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors", J Clin Endocrinol Metab, 89, pp.1512~1525 (2004)[DOI]
- Muller B, "Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit", Crit Care Med, 28, pp.977~983 (2000)[DOI]
- Baer G, "Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial", PLoS One, 8, pp.e68419~ (2013)[DOI]
- Esposito S, "Procalcitonin measurements for guiding antibiotictreatment in pediatric pneumonia", Respir Med, 105, pp.1939~1945 (2011)[DOI]
- Moulin F, "Procalcitonin in children admitted to hospital with community acquired pneumonia", Arch Dis Child, 84, pp.332~336 (2001)[DOI]
- Toikka P, "Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children", Pediatr Infect Dis J, 19, pp.598~602 (2000)[DOI]
- Stockmann C, "Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia", J Pediatric Infect Dis Soc, 7, pp.46~53 (2018)[DOI]
- Menendez R, "Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia", Chest, 141, pp.1537~1545 (2012)[DOI]
- Nascimento-Carvalho CM, "Procalcitonin is useful in identifying bacteraemia among children with pneumonia", Scand J Infect Dis, 42, pp.644~649 (2010)[DOI]